Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AH Realty Trust, Inc.AHRT · Entity 5324 | Director | September 28, 2026 | September 29, 2026 |
| Chiron Real Estate Inc.XRN · Entity 5421 | Director | May 20, 2026 | May 21, 2026 |
| IMH Financial CorpNONE · Entity 11943 | Director | June 29, 2020 | July 02, 2020 |
| NETSTREIT Corp.NTST · Entity 4483 | Director | February 26, 2026 | March 02, 2026 |
| NRX Pharmaceuticals, Inc.BRPAU · Entity 6523 | Director · CFO | November 20, 2017 | December 05, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AH Realty Trust, Inc.
Report date September 28, 2026 · Filed September 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,000 |
Reported balance
After 2026-09-28 transaction · row 1
1 source rowRow 1 · 2026-09-28 · Purchase · Acquired 3,000 · Balance 3,000 |
| Time-Based LTIP UnitsSEC Table II · derivative / convertible security | Direct | 11,695 |
Reported balance
Holding disclosure · report date 2026-09-28 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 11,695 F1: Represents Time-Based LTIP Units ("Time-Based LTIP Units") in AH Realty Trust, LP (the "Operating Partnership"), the operating partnership of AH Realty Trust, Inc. (the "Company"), and of which the Company is the general partner. Under the agreement of limited partnership of the Operating Partnership (the "OP Agreement") and subject to conditions set forth in the OP Agreement, following the date on which the Time-Based LTIP Units vest, Time-Based LTIP Units are convertible into common units of limited partnership interest in the Operating Partnership ("Common Units"), at the holder's option. Under the award agreement pursuant to which the Time-Based LTIP Units were granted to the reporting person, except in connection with a Change of Control (as defined in the OP Agreement), the Time-Based LTIP Units may not be converted to Common Units until two years following the date of grant. Time-Based LTIP Units have no expiration date. F2: Each Common Unit is redeemable for cash equal to the then-current market value of one share of the Company's common stock or, at the election of the Company, one share of the Company's common stock. Common Units have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Time-Based LTIP Units ("Time-Based LTIP Units") in AH Realty Trust, LP (the "Operating Partnership"), the operating partnership of AH Realty Trust, Inc. (the "Company"), and of which the Company is the general partner. Under the agreement of limited partnership of the Operating Partnership (the "OP Agreement") and subject to conditions set forth in the OP Agreement, following the date on which the Time-Based LTIP Units vest, Time-Based LTIP Units are convertible into common units of limited partnership interest in the Operating Partnership ("Common Units"), at the holder's option. Under the award agreement pursuant to which the Time-Based LTIP Units were granted to the reporting person, except in connection with a Change of Control (as defined in the OP Agreement), the Time-Based LTIP Units may not be converted to Common Units until two years following the date of grant. Time-Based LTIP Units have no expiration date.
F2: Each Common Unit is redeemable for cash equal to the then-current market value of one share of the Company's common stock or, at the election of the Company, one share of the Company's common stock. Common Units have no expiration date.
Chiron Real Estate Inc.
Report date May 20, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| LTIP Unit (Right to Buy)SEC Table II · derivative / convertible security | Direct | 12,414 |
Reported balance
After 2026-05-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 2,497 · Balance 12,414 F1: Represents units of limited partnership interest ("LTIP Units") in Chiron Real Estate LP (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 20, 2027, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F3: On September 19, 2025, the Issuer effected a reverse stock split of the Issuer's issued and outstanding shares of Common Stock at a ratio of 1-for-5. As a result, the amount of LTIP Units reflected in this filing is on a post-split adjusted basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents units of limited partnership interest ("LTIP Units") in Chiron Real Estate LP (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 20, 2027, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.
F2: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.
F3: On September 19, 2025, the Issuer effected a reverse stock split of the Issuer's issued and outstanding shares of Common Stock at a ratio of 1-for-5. As a result, the amount of LTIP Units reflected in this filing is on a post-split adjusted basis.
IMH Financial Corp
Report date June 29, 2020 · Filed July 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Voting Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 75,000 |
Reported balance
After 2020-06-29 transaction · row 1
1 source rowRow 1 · 2020-06-29 · Grant · Acquired 15,645 · Balance 75,000 F1: Effective on June 29, 2020, the reporting person entered into a Restricted Stock Award Agreement pursuant to the 2014 IMH Financial Corporation Non-Employee Director Compensation Plan under which the Reporting person was granted a total of 15,645 shares of restricted common stock which vested on June 30, 2020 and for which the reporting person has full voting rights. No commission or other remuneration was paid or received by the issuer in connection with this issuance. |
Filing footnotes · ownership attribution and instrument terms
F1: Effective on June 29, 2020, the reporting person entered into a Restricted Stock Award Agreement pursuant to the 2014 IMH Financial Corporation Non-Employee Director Compensation Plan under which the Reporting person was granted a total of 15,645 shares of restricted common stock which vested on June 30, 2020 and for which the reporting person has full voting rights. No commission or other remuneration was paid or received by the issuer in connection with this issuance.
NETSTREIT Corp.
Report date February 26, 2026 · Filed March 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,315 |
Reported balance
After 2026-02-26 transaction · row 1
1 source rowRow 1 · 2026-02-26 · Exercise / conversion · Acquired 7,192 · Balance 26,315 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock upon vesting. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 5,526 |
Reported balance
After 2026-02-26 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-02-26 · Exercise / conversion · Disposed 7,192 · Balance 5,526 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock upon vesting. F4: On February 26, 2025, the reporting person was granted 7,192 RSUs pursuant to the Issuer's Amended and Restated 2019 Omnibus Incentive Compensation Plan, vesting 100% on the first anniversary of the grant date, generally subject to continued service as a director through the vesting date. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote 2 | 2,639 |
Reported balance
Holding disclosure · report date 2026-02-26 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,639 F2: Held indirectly through the Lori B. Wittman Revocable Trust, of which she is the trustee. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote 3 | 1,111 |
Reported balance
Holding disclosure · report date 2026-02-26 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,111 F3: Held indirectly through a joint account with her husband. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock upon vesting.
F2: Held indirectly through the Lori B. Wittman Revocable Trust, of which she is the trustee.
F3: Held indirectly through a joint account with her husband.
F4: On February 26, 2025, the reporting person was granted 7,192 RSUs pursuant to the Issuer's Amended and Restated 2019 Omnibus Incentive Compensation Plan, vesting 100% on the first anniversary of the grant date, generally subject to continued service as a director through the vesting date.
NRX Pharmaceuticals, Inc.
Report date November 20, 2017 · Filed December 05, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 0 |
Reported balance
Holding disclosure · report date 2017-11-20 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 F1: Ms. Wittman does not beneficially own any securities of the issuer. However, Ms. Wittman has a pecuniary interest in securities of the issuer through her ownership of membership interests of Big Rock Partners Sponsor, LLC. Ms. Wittman disclaims beneficial ownership of such securities, except to the extent of her pecuniary interests. |
Filing footnotes · ownership attribution and instrument terms
F1: Ms. Wittman does not beneficially own any securities of the issuer. However, Ms. Wittman has a pecuniary interest in securities of the issuer through her ownership of membership interests of Big Rock Partners Sponsor, LLC. Ms. Wittman disclaims beneficial ownership of such securities, except to the extent of her pecuniary interests.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Care Capital Properties, Inc.
Report date August 17, 2017 · Filed August 21, 2017
Section 16 reporting ended · disclosed 2017-08-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2017-08-17 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2017-08-17 · Grant · Acquired 14,768 · Balance 93,521 F1: Pursuant to an Agreement and Plan of Merger, dated May 7, 2017 (the "Merger Agreement"), by and among Sabra Health Care REIT, Inc., a Maryland corporation ("Sabra"), Sabra Health Care Limited Partnership, a Delaware limited partnership, PR Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Sabra ("Merger Sub"), Care Capital Properties, Inc., a Delaware corporation (the "Issuer"), and Care Capital Properties, LP, a Delaware limited partnership, the outstanding performance-based restricted stock units held by the Reporting Person immediately prior to the effective time of the merger (the "Merger") of Issuer with and into Merger Sub vested in full and were converted into an aggregate 14,768 shares of Issuer common stock. Row 2 · 2017-08-17 · Disposition to issuer · Disposed 93,521 · Balance 0 F2: Pursuant to the Merger Agreement, each outstanding share of the Issuer's common stock was exchanged on August 17, 2017 for the right to receive 1.123 newly issued shares of Sabra's common stock (the "Merger Consideration"), subject to certain adjustments as set forth in the Merger Agreement. The closing price of shares of Sabra's common stock on August 16, 2017 was $21.72 per share. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.07 · Expires 2022-03-09 | Direct | 0 |
Reported balance
After 2017-08-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-08-17 · Disposition to issuer · Disposed 1,620 · Balance 0 F6: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option. F3: Fully vested. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.37 · Expires 2023-03-08 | Direct | 0 |
Reported balance
After 2017-08-17 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-08-17 · Disposition to issuer · Disposed 8,577 · Balance 0 F6: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option. F3: Fully vested. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $29.57 · Expires 2024-03-07 | Direct | 0 |
Reported balance
After 2017-08-17 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-08-17 · Disposition to issuer · Disposed 25,611 · Balance 0 F6: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option. F3: Fully vested. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.16 · Expires 2025-03-06 | Direct | 0 |
Reported balance
After 2017-08-17 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-08-17 · Disposition to issuer · Disposed 28,441 · Balance 0 F6: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option. F4: A portion of these options were scheduled to vest on March 6, 2018. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $29.94 · Expires 2026-01-27 | Direct | 0 |
Reported balance
After 2017-08-17 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-08-17 · Disposition to issuer · Disposed 57,851 · Balance 0 F6: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option. F5: These options were granted on January 27, 2016 and were scheduled to vest in three equal installments beginning on the first anniversary of the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to an Agreement and Plan of Merger, dated May 7, 2017 (the "Merger Agreement"), by and among Sabra Health Care REIT, Inc., a Maryland corporation ("Sabra"), Sabra Health Care Limited Partnership, a Delaware limited partnership, PR Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Sabra ("Merger Sub"), Care Capital Properties, Inc., a Delaware corporation (the "Issuer"), and Care Capital Properties, LP, a Delaware limited partnership, the outstanding performance-based restricted stock units held by the Reporting Person immediately prior to the effective time of the merger (the "Merger") of Issuer with and into Merger Sub vested in full and were converted into an aggregate 14,768 shares of Issuer common stock.
F2: Pursuant to the Merger Agreement, each outstanding share of the Issuer's common stock was exchanged on August 17, 2017 for the right to receive 1.123 newly issued shares of Sabra's common stock (the "Merger Consideration"), subject to certain adjustments as set forth in the Merger Agreement. The closing price of shares of Sabra's common stock on August 16, 2017 was $21.72 per share.
F3: Fully vested.
F4: A portion of these options were scheduled to vest on March 6, 2018.
F5: These options were granted on January 27, 2016 and were scheduled to vest in three equal installments beginning on the first anniversary of the date of the grant.
F6: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2017 Filed Mar 8, 2017 21:31 UTC | Care Capital Properties, Inc. CCP · Entity 173690 | Tax withholdingCommon Stock | 585 | $25.72 | $15,046.20 |
DisclosureSEC source: 0001639947-17-000033 · wf-form4_148900866337681.xml · nonDerivative · entry 1 Wittman Lori · CIK 0001615562 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,102 F1 · shares: Represents shares withheld to pay the taxes on the vesting of restricted stock originally granted by Ventas, Inc. ("Ventas") on March 6, 2015 under the Ventas 2012 Incentive Plan (the "Ventas Plan") that was converted into the Issuer's restricted stock in connection with the spin-off of the Issuer from Ventas on August 17, 2015. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 21:38 UTC | Care Capital Properties, Inc. CCP · Entity 173690 | Tax withholdingCommon Stock | 2,896 | $25.46 | $73,732.16 |
DisclosureSEC source: 0001639947-17-000023 · wf-form4_148676267072380.xml · nonDerivative · entry 2 Wittman Lori · CIK 0001615562 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,687 F2 · shares: Represents shares withheld to pay the taxes on the vesting of restricted stock granted on February 8, 2017 under the Plan. F3 · balance_after: As of February 8, 2017, Reporting Person also owns options to purchase an aggregate of 122,100 shares of Issuer's common stock. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 21:38 UTC | Care Capital Properties, Inc. CCP · Entity 173690 | GrantCommon Stock | 28,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001639947-17-000023 · wf-form4_148676267072380.xml · nonDerivative · entry 1 Wittman Lori · CIK 0001615562 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,583 F1 · shares: Restricted stock granted by Issuer pursuant to the Care Capital Properties, Inc. 2015 Incentive Plan (the "Plan"). This restricted stock vests in three equal annual installments beginning on the date of the grant. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 21:32 UTC | Care Capital Properties, Inc. CCP · Entity 173690 | Tax withholdingCommon Stock | 1,337 | $24.51 | $32,769.87 |
DisclosureSEC source: 0001639947-17-000013 · wf-form4_148589833404899.xml · nonDerivative · entry 1 Wittman Lori · CIK 0001615562 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,508 F1 · shares: Represents shares withheld to pay the taxes on the vesting of restricted stock granted on January 27, 2016 under the Care Capital Properties, Inc. 2015 Incentive Plan. F2 · balance_after: As of January 27, 2017, Reporting Person also owns options to purchase an aggregate of 122,100 shares of Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.